Raymond James Starts Immunovant (IMVT) at Outperform
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Price: $39.49 -1.03%
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 32
Rating Summary:
16 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 32
Join SI Premium – FREE
Raymond James analyst Danielle Brill initiates coverage on Immunovant (NASDAQ: IMVT) with a Outperform rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $32.59 yesterday.
You May Also Be Interested In
- Scotiabank Starts Webull (BULL) at Sector Outperform
- Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
- Scotiabank Starts Corpay (CPAY) at Sector Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
